MAPK/ERK


The mitogen-activated protein kinase (MAPK) is a highly conserved family of serine/threonine kinases that mediate a board range of cellular processes, including proliferation, differentiation, motility, migration, stress response, apoptosis and survival. The activation of MAPK involves signaling pathways consisting of MAPK kinase (i.e. MAPKKK or MEKK) that activates MAPK/ERK (i.e. MAPKK or MEK). A variety of extracellular signals such as mitogens, cytokines, growth factors, and environmental stressors stimulate a phosphorylation-dependent increase in the activity of MAPK.
Activated MAPKs transduce the phosphorylation and activation of MAPK-activated protein kinases (MAPKAPKs), e.g. RSK, MSK, or MNK family, and MK2/3/5. There are three main MAPK families, signal-regulated kinase 1 and 2 (Erk1/2 or p44/42), the c-Jun N-terminal kinases 1-3 (JNK1-3)/ stress activated protein kinases (SAPK1A, 1B, 1C), the p38 isoforms (p38α, β, γ, and δ). ERK signaling is involved in cell division, migration and survival. p38 MAPK and JNK/SAPK pathways are activated by cellular stress. The p38 MAPK pathway regulates cell motility, transcription, and chromatin remodeling. JNK/SAPK signaling affects apoptosis and inflammation. Dysregulation of MAPK pathway results in tumorgenesis and other pathological conditions.
-
B8309 CyclosporinSummary: A class of cyclic decapeptide compounds produced by soil fungi, whose primary targets of action are the cyclophilin family. -
B8388 ERK5-in-1 -
B8501 GW284543Summary: Selective MEK5 inhibitor -
B8513 (Rac)-Antineoplaston A10Summary: Ras inhibitor -
B8535 SKF86002Summary: An orally active p38 MAPK inhibitor -
B5727 PD 334581Summary: MEK1 inhibitor -
A9907 MEK Inhibitor SetSummary: For phosphorylation and dephosphorylation applications -
B7784 AL 8697Target: p38Summary: p38α inhibitor,potent and selective -
B7791 6-Bnz-cAMP sodium saltSummary: cAMP analog,PKA activator -
A9501 OTS514Summary: TOPK inhibitor,highly potent

